- Home
- UAMY vs RNAC Comparison
UAMY vs RNAC Comparison
Compare UAMY & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAMY
- RNAC
- Stock Information
- Founded
- UAMY 1968
- RNAC 2007
- Country
- UAMY United States
- RNAC United States
- Employees
- UAMY N/A
- RNAC N/A
- Industry
- UAMY Metal Fabrications
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- UAMY Industrials
- RNAC Health Care
- Exchange
- UAMY Nasdaq
- RNAC Nasdaq
- Market Cap
- UAMY 316.8M
- RNAC 276.3M
- IPO Year
- UAMY N/A
- RNAC 2016
- Fundamental
- Price
- UAMY $4.54
- RNAC $10.05
- Analyst Decision
- UAMY Strong Buy
- RNAC Strong Buy
- Analyst Count
- UAMY 5
- RNAC 4
- Target Price
- UAMY $3.60
- RNAC $40.00
- AVG Volume (30 Days)
- UAMY 6.3M
- RNAC 48.4K
- Earning Date
- UAMY 08-12-2025
- RNAC 08-07-2025
- Dividend Yield
- UAMY N/A
- RNAC N/A
- EPS Growth
- UAMY N/A
- RNAC N/A
- EPS
- UAMY N/A
- RNAC N/A
- Revenue
- UAMY $25,728,046.00
- RNAC $1,026,000.00
- Revenue This Year
- UAMY $209.07
- RNAC N/A
- Revenue Next Year
- UAMY $98.95
- RNAC N/A
- P/E Ratio
- UAMY N/A
- RNAC N/A
- Revenue Growth
- UAMY 134.91
- RNAC N/A
- 52 Week Low
- UAMY $0.49
- RNAC $8.46
- 52 Week High
- UAMY $5.13
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- UAMY 64.05
- RNAC 34.71
- Support Level
- UAMY $4.38
- RNAC $10.50
- Resistance Level
- UAMY $5.13
- RNAC $11.80
- Average True Range (ATR)
- UAMY 0.40
- RNAC 0.56
- MACD
- UAMY 0.01
- RNAC -0.11
- Stochastic Oscillator
- UAMY 69.56
- RNAC 0.45
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.